Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Alopecia areata is complex, often recurring, and needs personalized treatment, especially with other health issues.

Mercury allergy linked to specific genes may contribute to burning mouth syndrome, and silicon might play a role in maintaining healthy hair.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Insulin therapy helped a man with autoimmune issues regrow his hair.

Patients with one autoimmune disease should be checked for other autoimmune disorders.

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

Certain genes are linked to type 1 and type 2 diabetes in kids, and changes in these genes can also cause other diabetes-related conditions.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

A genetic marker linked to a type of hair loss was found in most patients studied.

Both HLA-B and MICA are independently linked to alopecia areata.

Most women with ankylosing spondylitis tested positive for HLA-B27, suggesting it's useful for diagnosis.

Corticosteroid therapy reduces specific immune cells and promotes hair growth in alopecia areata patients.

Alopecia areata can be transferred through stem cell transplants from affected siblings.

B2m-free HLA variants may be a new class of HLA important in immune responses and diseases.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Certain genetic variants are linked to frontal fibrosing alopecia in Spanish patients.

Certain genes are linked to the risk of developing Alopecia Areata.

HLA-DRB5 and other genes may be linked to alopecia universalis.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.